People · Operator
Named in public records as an officer, director or promoter · active 2023–2025 · Other Health Care, Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Clarapath, Inc. | — | Other Health Care | Series B | $40.2M | $348.1M | 2023 |
| Tamarind Bio, Inc. | — | Biotech | Series A | $13.6M | $47.5M | 2025 |
SHERRY LIU at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside SHERRY LIU on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Laurence Kraemer | 1 | 5 |
| Charles Cantor | 1 | 2 |
| Joaquin Garcia | 1 | 1 |
| Robert Stallone | 1 | 1 |
| Partha Mitra | 1 | 1 |
| Eric Feinstein | 1 | 1 |
| Michael Shelanksi | 1 | 1 |
| Michael Shelanski | 1 | 1 |
| DENIZ KAVI | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.